Sign in Pull a receipt

LBRX

LB PHARMACEUTICALS INC

Healthcare · Biotechnology

$149.50 sample

-1.25 (-0.83%) 1D

Market cap

$885.4B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-02

Alerts

8

Price$149.50 +4.96% 3M daily closessample

155.56140.04

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider buy: 10% owner
Oct 15INSInsider sell: Chief Executive Officer
Oct 08INSInsider sell: General Counsel
Oct 02SECDEF 14A filed
Sep 29INSInsider sell: Chief Financial Officer
Sep 22INSInsider sell: General Counsel
Sep 14INSInsider buy: 10% owner
Sep 07SEC10-Q filed

Sign up to see the real LBRX record →

Company facts

SEC EDGAR registration

Name: LB PHARMACEUTICALS INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -25sample, -100 to +100
Reporting currency: USD

Who is positioning in LBRX

sample

Insiders: 12 insider transactions over 90 days, net selling, $688.8M
Congress: 4 members traded over 90 days
Institutions · 13F: 24 funds hold $15.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.8B +20.9% y/y

Q4 2024Q3 2026

Inventory$17.0B +2.7% y/y

Q4 2024Q3 2026

Accounts receivable$13.1B +12.7% y/y

Q4 2024Q3 2026

Total debt$37.0B +12.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $610.8B +1.3% 3M
Sample peer B: $105.3B +11.5% 3M
Sample peer C: $92.5B +16.1% 3M
Sample peer D: $869.0B -4.1% 3M
Sample peer E: $250.7B +13.2% 3M